End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.2 CNY | +0.39% | -8.52% | -22.79% |
Business Summary
Number of employees: 1,129
Sales per Business
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Cardiovascular and Cerebrovascular
25.0
%
| 34 | 5.9 % | 191 | 25.0 % | +468.48% |
Liver Diseases
23.6
%
| 157 | 27.6 % | 180 | 23.6 % | +14.85% |
Nervous System
16.1
%
| 90 | 15.9 % | 123 | 16.1 % | +36.08% |
Antibacterial
11.0
%
| 115 | 20.1 % | 84 | 11.0 % | -26.94% |
Gout
9.4
%
| 46 | 8.1 % | 72 | 9.4 % | +54.76% |
Other
7.2
%
| 55 | 9.7 % | 55 | 7.2 % | -0.45% |
Technical Services
4.2
%
| 33 | 5.7 % | 32 | 4.2 % | -2.62% |
Prostaglandin
2.5
%
| 14 | 2.5 % | 19 | 2.5 % | +35.50% |
Respiratory System
0.5
%
| 10 | 1.8 % | 4 | 0.5 % | -60.19% |
Anti-tumor
0.3
%
| 15 | 2.6 % | 3 | 0.3 % | -82.63% |
High-end Fluorine
0.3
%
| 1 | 0.2 % | 2 | 0.3 % | +137.25% |
Sales per region
CNY in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
International
57.3
%
| 306 | 53.7 % | 438 | 57.3 % | +43.36% |
China
42.7
%
| 264 | 46.3 % | 326 | 42.7 % | +23.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhi Guo Zheng
CEO | Chief Executive Officer | 53 | 14-12-14 |
Ding Min Zhu
DFI | Director of Finance/CFO | 57 | 21-11-01 |
Hua Dong Zhang
BRD | Director/Board Member | 47 | 14-12-13 |
Tuan Tuan Wang
IRC | Investor Relations Contact | - | - |
Xiao Chen Ying
SEC | Corporate Secretary | 43 | 21-12-24 |
Yu Zhong
PRN | Corporate Officer/Principal | 62 | 20-07-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Fei Chen
BRD | Director/Board Member | 44 | 15-01-07 |
Zhi Guo Zheng
CEO | Chief Executive Officer | 53 | 14-12-14 |
Bing Liu
FOU | Founder | 55 | 14-12-13 |
Hua Dong Zhang
BRD | Director/Board Member | 47 | 14-12-13 |
Shi Lan Zheng
BRD | Director/Board Member | 49 | 14-12-13 |
Yu Liu
BRD | Director/Board Member | 42 | 14-12-14 |
Fu Li Zhang
BRD | Director/Board Member | 56 | 17-12-12 |
He Min Zhu
BRD | Director/Board Member | 37 | 12-12-31 |
Ming Min Luo
BRD | Director/Board Member | 51 | 20-12-12 |
Guan Neng Yu
BRD | Director/Board Member | 37 | 12-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 593,069,389 | 237,411,769 ( 40.03 %) | 0 | 40.03 % |
Company contact information
Zhejiang Ausun Pharmaceutical Co., Ltd.
5 Donghai Fourth Avenue Linhai Park
317016, Taizhou
+
http://www.ausunpharm.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.79% | 837M | |
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |
- Stock
- Equities
- Stock Zhejiang Ausun Pharmaceutical Co., Ltd. - Shanghai S.E.
- Company Zhejiang Ausun Pharmaceutical Co., Ltd.